| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 7,960 | $190 | $1.5M |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 620 | $1,340 | $824.3K |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 1,260 | $490 | $614.9K |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 80 | $2,210 | $172.1K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 580 | $280 | $164.1K |
| 78452 | In this procedure, the provider performs multiple SPECT studies of the heart to determine the areas of deficient blood flow. The goal of the procedure is to determine areas that have deficient blood… | 1,120 | $150 | $163.2K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 110 | $1,300 | $137.4K |
| 78608 | In this diagnostic procedure, the provider performs PET, positron emission tomography, a type of nuclear imaging test. It tells how the brain is functioning with information on metabolism, such as… | 40 | $1,430 | $57.2K |
| A9592 | Copper cu-64, dotatate, diagnostic, 1 millicurie | 70 | $850 | $56.9K |
| 78830 | The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging… | 200 | $240 | $46K |